Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of DEH113 in Primary Dysmenorrhea
NCT06555549Not yet recruiting
- Sponsor
- EMS
- Start
- Sep 2024
- Primary completion
- Sep 2025
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial in primary dysmenorrhea (PD) comparing DEH113 with Placebo (2 arms). Primary endpoints: Sum of Total Pain Relief and Sum of Pain Intensity Difference at 8 hours. Planned start Sep 2024; status: not yet recruiting.
02
Drugs
dexibuprofen
03
Conditions
primary dysmenorrhea (PD)
Beyond the preview
Go deeper on NCT06555549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06555549.